MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

To test whether the neurons were functional, the researchers injected them into the brains of rats treated with a neurotoxin ...

Two rodent models that spontaneously develop type 1 diabetes, the NOD (non-obese diabetic) mouse and the BB (BioBreeding) rat, have allowed ... is extremely broad; symptoms occur at any time ...

Type 2 diabetes (T2D) may impair reward processing in the brain, as shown in a rat maze experiment. Rats with T2D exhibited weaker reward signals in the anterior cingulate cortex (ACC) and spent ...

James Hyman and colleagues, from the University of Nevada, Las Vegas, used a rat model of T2D that affects only males to explore whether diabetes affects ACC activity and behavior. Their work is ...